- Max Synapse LLC and Super Flora Probiotic, LLC (dietary supplements) ( )
- The First Wealth is Health: Protecting Competition in Healthcare Markets ( )
- Synergy Pharmaceuticals, Inc. (Trulance prescription drug) ( )
- Diagnosing the Treatments: Issues in Post-Patent Pharmaceutical Markets ( )
- Aqua Health Labs, Inc. (PhytOriginal dietary supplements) ( )
- Tennessee Department of Health, Certificate of Public Advantage Hearing Testimony ( )
- Statement of the Federal Trade Commission On the Commission Vote To Close the Investigation of the Texas Medical Board’s Conduct ( )
- Opening Remarks for FTC Workshop, Now Hear This: Competition, Innovation, and Consumer Protection in Hearing Health Care ( )
- Cybersecurity & the Healthcare Industry: The FTC’s Tools for Tackling New Threats ( )
- To Know Where You’re Going, Look at Where You’ve Been ( )
- Concurring Statement of Commissioner Maureen K. Ohlhausen In the Matter of Mallinckrodt ARD Inc. ( )
- Keynote Remarks to the Federal Communications Bar - Practicing Law Institute, "The Challenges of New Technologies at a Time of Transition" ( )
- Tennessee Department of Health Public Hearing Testimony ( )
- Concurring Statement of Maureen K. Ohlhausen In the Matter of CentraCare Health System ( )
- Keynote Address of FTC Chairwoman Edith Ramirez ( )
- FTC Research, Enforcement, and Advocacy at the Intersection of Antitrust and IP ( )
- Competition Law: Keeping Pace in a Digital Age ( )
- Dissenting Statement of Commissioner Maureen K. Ohlhausen In the Matter of Endo Pharmaceuticals Inc. ( )
- Reflections on an Active Year in Merger Enforcement ( )
- Taking the humble approach: An in-depth Q&A with Maureen Ohlhausen ( )
- Certificate of Need Laws: A Prescription for Higher Costs ( )
- The FTC: A Framework for Promoting Competition and Protecting Consumers ( )
- Concurring Statement of Commissioner Julie Brill on the Joint Statement of the Federal Trade Commission and the Antitrust Division of the U.S. Department of Justice to the Virginia Certificate of Public Need Work Group ( )
- Brother May I?: The Challenge of Competitor Control Over Market Entry ( )
- Statement of Chairwoman Edith Ramirez In the Matter of LabMD, Inc. ( )
- Plymouth Direct, Inc. (BeActive Brace) ( )
- Statement of Chairwoman Edith Ramirez - In the Matter of LabMD, Inc. ( )
- Keynote Remarks of FTC Chairwoman Edith Ramirez ( )
- Brother, May I?: The Challenge of Competitor Control over Market Entry ( )
- Opening Remarks by FTC Chairwoman Edith Ramirez at Cephalon/Teva Settlement Press Conference ( )